|
⚲
|
| Keyboard |
| Lian Brian
✚
|
|
|---|---|
| CIK # | 0001614578 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001614578] | |
| 4 | [0001614578] | |
| SC 13G | [0001614578] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| LIAN Brian | Viking Therapeutics Inc | [2016-02-16] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Viking Therapeutics Inc | |
| Lian Brian | |
| Seelos Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2026-01-05 | Sell | 41,276 | $34.22 | 1,412,465 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2026-01-05 | Sell | 132,454 | $32.29 | 4,276,940 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2026-01-05 | Sell | 53,279 | $33.38 | 1,778,453 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2026-01-05 | Sell | 6,400 | $35.07 | 224,448 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2026-01-02 | Grant | 224,080 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2026-01-02 | Grant | 78,400 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Stock Option (Right to Buy) · derivative
|
2026-01-02 | Grant | 176,300 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2025-10-28 | Sell | 38,989 | $35.01 | 1,365,005 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2025-10-27 | Grant | 70,084 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2025-07-03 | Sell | 26,889 | $27.80 | 747,514 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2025-07-02 | Grant | 48,333 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2025-01-06 | Sell | 19,000 | $43.32 | 823,080 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2025-01-06 | Sell | 175,490 | $42.68 | 7,489,913 |
|
Viking Therapeutics Inc VKTX
Stock Option (Right to Buy) · derivative
|
2025-01-03 | Grant | 78,300 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2025-01-03 | Grant | 92,800 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2025-01-03 | Grant | 163,333 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2024-09-20 | Option exercise | 166,130 | $7.77 | 1,290,830 |
|
Viking Therapeutics Inc VKTX
Stock Option (Right to Buy) · derivative
|
2024-09-20 | Option exercise | 166,130 | $0.00 | |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2024-09-20 | Sell | 119,874 | $71.15 | 8,529,035 |
|
Viking Therapeutics Inc VKTX
Common Stock, par value $0.00001 per share
|
2024-09-20 | Sell | 96,056 | $70.43 | 6,765,224 |
| showing 20 of 131 most recent transactions | |||||